购物车
全部删除
您的购物车当前为空
别名 PROTAC BRD9-binding moiety 1 hydrochloride (2097512-23-5 free base)
PROTAC BRD9-binding moiety 1 hydrochloride inhibits BRD9 activity by binding to BRD9, utilizing the PROTAC (Proteolysis Targeting Chimera) mechanism.

PROTAC BRD9-binding moiety 1 hydrochloride inhibits BRD9 activity by binding to BRD9, utilizing the PROTAC (Proteolysis Targeting Chimera) mechanism.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 3,740 | 待询 | |
| 10 mg | ¥ 6,230 | 待询 | |
| 25 mg | ¥ 12,400 | 待询 | |
| 50 mg | ¥ 17,400 | 待询 | |
| 100 mg | ¥ 27,400 | 待询 | |
| 200 mg | 待询 | 待询 | |
| 500 mg | 待询 | 待询 | |
| 1 mL x 10 mM (in DMSO) | ¥ 4,570 | 待询 |
PROTAC BRD9-binding moiety 1 hydrochloride 相关产品
| 产品描述 | PROTAC BRD9-binding moiety 1 hydrochloride inhibits BRD9 activity by binding to BRD9, utilizing the PROTAC (Proteolysis Targeting Chimera) mechanism. |
| 别名 | PROTAC BRD9-binding moiety 1 hydrochloride (2097512-23-5 free base) |
| 分子量 | 556.05 |
| 分子式 | C23H26ClN3O7S2 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 20.83 mg/mL (37.46 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
评论内容